Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer

Sep 12, 2017

Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

Sep 7, 2017

Heat Biologics Inc. Reports Second Quarter 2017 Results

Aug 14, 2017

Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics

Jul 3, 2017

Heat Biologics Appoints Damien Hallet as Vice President of CMC Development

Jul 3, 2017

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award

Jun 28, 2017

Heat Biologics to Present at the 2017 BIO International Convention

Jun 12, 2017

Heat Biologics to Present at the 2017 Marcum Microcap Conference

Jun 7, 2017

Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting

Jun 5, 2017

Heat Biologics to Present Poster at 2017 ASCO Annual Meeting

May 30, 2017